Search clinical trials for: Secukinmab

Total 192 results

Novartis Pharmaceuticals

Completed

Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

Psoriasis

United States
Novartis Pharmaceuticals

Completed

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. (PRIME)

Psoriasis

Germany
NeuroproteXeon, Inc.

Unknown

Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest (XePOHCAS)

Post-Cardiac Arrest Syndrome

United States, Denmark
Centre Hospitalier Universitaire, Amiens

Unknown

Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy (CAMFIB)

Liver Disease

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis (ROC-SPA)

Axial Spondyloarthritis

France, Monaco
Radboud University Medical Center
University Hospital, Ghent; ZonMw: The Netherlands Organisation for Health... and other collaborators

Active, not recruiting

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio)

Psoriasis | Psoriasis Vulgaris

Netherlands, Belgium
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Non-infectious Uveitis

United States, Germany
Peking Union Medical College Hospital

Recruiting

An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients

Psoriatic Arthritis

China
Novartis Pharmaceuticals

Completed

Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis (INVIGORATE 2)

Psoriatic Arthritis

United States, India, Greece, Thailand, Czechia, Philippines, Bulgaria, Russian Federation, Guatemala, South Africa, Malaysia, Colombia, Brazil, Poland, Turkey
Hamilton Health Sciences Corporation

Unknown

Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC (BOS-MRI)

Bronchiolitis Obliterans

Canada
Jiaolin Ning,MD

Unknown

Effect of Methylene Blue on Perioperative Organ Function in Patients With Obstructive Jaundice

Jaundice

China
Novartis Pharmaceuticals

Completed

Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) (SURPASS)

Ankylosing Spondylitis

Taiwan, Netherlands, United Kingdom, Germany, Korea, Republic of, Israel, United States, Belgium, Greece, Philippines, Russian Federation, Spain, Turkey, Portugal, Mexico, Peru, Denmark, France, Czechia, Australia, Canada, Poland, J... and more
Qilu Hospital of Shandong University

Active, not recruiting

The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients

Ankylosing Spondylitis

China
University Hospital, Ghent
Belgium Health Care Knowledge Centre

Not yet recruiting

Proactive TDM Versus Standard Use of Biologics in Psoriasis (HELIOS)

Psoriasis Vulgaris

Belgium
Chao Ji

Completed

Biologic Therapy for Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

China
Novartis Pharmaceuticals

Completed

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) (NURTURE 1)

Rheumatoid Arthritis

Colombia, United States, Italy, Germany, Spain, France, Hungary, Bulgaria, Brazil, Czech Republic, Russian Federation, Slovakia, Canada, Mexico, Romania
Guangdong Provincial Hospital of Traditional Chinese...

Unknown

Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis

Psoriasis

China
Abbott

Completed

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors (VITAL)

Diabetic Nephropathy | Chronic Kidney Disease

United States, Germany, Greece, Italy, Netherlands, Poland, Portugal, Puerto Rico, Spain, Taiwan
Pierrel Research Europe GmbH
Roche Pharma AG

Terminated

Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation (CONVINCE)

Allogeneic Stem Cell Transplantation

Austria, Germany, Spain
Lomonosov Moscow State University Medical Research...

Completed

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19 (COLORIT)

COVID 19

Russian Federation
Novartis Pharmaceuticals

Completed

A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis (TitAIN)

Giant Cell Arteritis

Germany
University of Virginia

Recruiting

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

Chronic Obstructive Pulmonary Disease

United States
Novartis Pharmaceuticals

Completed

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis (STEPin)

Plaque Psoriasis

Spain, United Kingdom, Estonia, Germany, Bulgaria, Finland, Hungary, Poland, Argentina, Canada, Denmark, Switzerland, Sweden
Eli Lilly and Company

Completed

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

Psoriasis

United States, Spain, Puerto Rico, Canada, France, Korea, Republic of, Australia, Italy, Israel, Japan, Germany, Argentina, Czechia, Hungary, Poland, United Kingdom
Novartis Pharmaceuticals

Completed

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis (FIXTURE)

Chronic Plaque Psoriasis

Germany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
Stanford University

Withdrawn

In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?

Acid Reflux | Stridor | Laryngomalacia

United States
Prof. Dr. Stephan Weidinger

Recruiting

Molecular Signatures in Inflammatory Skin Disease (MSID)

Psoriasis | Atopic Dermatitis

Germany
Universita di Verona

Unknown

Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome

Psoriasis | Metabolic Syndrome

Italy
BeiGene

Active, not recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL (SEQUOIA)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States, China, Taiwan, Belgium, France, United Kingdom, Spain, New Zealand, Australia, Czechia, Italy, Poland, Russian Federation, Sweden, Austria
Belfast Health and Social Care Trust
Queen's University, Belfast; British Medical Association; Psoriasis and Psoriatic...

Completed

Ultrasound Enthesitis Response in Psoriatic Arthritis

Psoriasis | Psoriatic Arthritis | Enthesitis

United Kingdom
Horizon Pharma Ireland, Ltd., Dublin Ireland

Completed

Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment

Ulcer
Singapore General Hospital
Translational Immunology Institute

Not yet recruiting

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
Second Affiliated Hospital, School of Medicine,...

Recruiting

Immunoclassification of Psoriasis: a Strategy for Precision Medicine

Psoriasis | Immunoclassification

China
Simon Krabbe
Zealand University Hospital; University of Aarhus; University of Southern Denmark

Completed

Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs

Rheumatoid Arthritis | Psoriatic Arthritis | Spondyloarthritis
University of Athens

Recruiting

Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

Psoriasis

Greece
Jeffrey Curtis
Bristol-Myers Squibb; Eli Lilly and Company; University of Pennsylvania; Novartis; Pfiz... and other collaborators

Recruiting

COVID-19 VaccinE Response in Rheumatology Patients (COVER)

Rheumatoid Arthritis | Spondylarthritis | Psoriatic Arthritis

United States
Joanneum Research Forschungsgesellschaft mbH

Completed

An Exploratory Study in Healthy Volunteers to Investigate the Cross-talk Between Local Drug Concentrations in the Skin and Systemic Concentrations During Topical Bioequivalence Studies Using Dermal Sampling Techniques

Healthy | Dermal Pharmacokinetic Measurement

Austria
Pharmaceutical Research Unit, Jordan

Completed

Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions

Healthy

Jordan
Seoul National University Hospital

Recruiting

Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Korea, Republic of
University of Erlangen-Nürnberg Medical School

Recruiting

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Psoriatic Arthritis | Withdrawal | Reduction

Germany
Mercy Facial Plastic Surgery Center

Completed

Anesthetics in Rhytidoplasty - A Comparison Study

Rhytidoplasty

United States

Search clinical trials for: Secukinmab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations